Clinical Trial Update: Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating an acetylcysteine rinse to reduce saliva thickness and mucositis in head and neck cancer patients undergoing radiation therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Mucositis

Drugs mentioned

• Acetylcysteine rinse (acetylcysteine)

Snippet

Sponsor: Mayo Clinic | Conditions: Mucositis, Oral Complications | Phase 2 | Status: COMPLETED | Results posted: 2019-04-05